Ferriprox® (deferiprone) – New indication, expanded indication
May 1, 2021 - Chiesi Global Rare Diseases announced the FDA approval of Ferriprox (deferiprone), for the treatment of transfusional iron overload in adult and pediatric patients 3 years of age and older with sickle cell disease or other anemias.
Top